Endogenous Cushing Syndrome

被引:0
|
作者
Tauveron, Igor [1 ,2 ,3 ,4 ]
Batisse-Lignier, Marie [2 ,3 ,4 ]
Martinez, Antoine [1 ,3 ,4 ]
Val, Pierre [1 ,3 ,4 ]
Maqdasy, Salwan [1 ,2 ,3 ,4 ]
机构
[1] Univ Clermont Auvergne, UMR GReD, 28 Pl Henri Dunant,BP 38, F-63001 Clermont Ferrand, France
[2] CHU Clermont Ferrand, Serv Endocrinol, 58 Rue Montalembert, F-63000 Clermont Ferrand, France
[3] Hop Cochin, Ctr Competence Filiere Malad Rares Endocriniennes, 27 Rue Faubourg St Jacques, F-75014 Paris, France
[4] Inst Natl Canc, Reseau Comete, Canc Surrenale, 52 Ave Andre Morizet, F-92513 Boulogne, France
来源
ACTUALITES PHARMACEUTIQUES | 2019年 / 58卷 / 585期
关键词
adrenal cortex carcinoma; adrenocorticotropic hormone; Cushing's disease; paraneoplastic Cushing's syndrome; DIAGNOSIS;
D O I
10.1016/j.actpha.2019.02.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Endogenous Cushing's syndromes. Once Cushing's syndrome has been clinically confirmed, the measurement of adrenocorticotropic hormone (ACTH) levels enables the aetiology to be determined. ACTH-dependent forms are due primarily to Cushing's disease, paraneoplastic syndromes, uncommon, are associated with numerous tumours, mainly bronchial, and ACTH-independent forms, rare, with malignant or benign tumours. (c) 2019 Elsevier Masson SAS. All rights reserved
引用
收藏
页码:23 / 27
页数:5
相关论文
共 50 条
  • [1] Endogenous Cushing's syndrome during pregnancy
    Younes, Nada
    St-Jean, Matthieu
    Bourdeau, Isabelle
    Lacroix, Andre
    [J]. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2023, 24 (01): : 23 - 38
  • [2] FINAL STATURE IN PATIENTS WITH ENDOGENOUS CUSHING SYNDROME
    MAGIAKOU, MA
    MASTORAKOS, G
    CHROUSOS, GP
    [J]. PEDIATRIC RESEARCH, 1994, 35 (04) : A103 - A103
  • [3] Endogenous Cushing's syndrome and cancer risk
    Rudman, Yaron
    Fleseriu, Maria
    Dery, Laura
    Masri-Iraqi, Hiba
    Sasson, Liat
    Shochat, Tzipora
    Kushnir, Shiri
    Shimon, Ilan
    Akirov, Amit
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2024, 191 (02) : 223 - 231
  • [4] Endogenous Cushing’s syndrome during pregnancy
    Nada Younes
    Matthieu St-Jean
    Isabelle Bourdeau
    André Lacroix
    [J]. Reviews in Endocrine and Metabolic Disorders, 2023, 24 : 23 - 38
  • [5] Mortality in Patients with Endogenous Cushing's Syndrome
    Javanmard, Pedram
    Duan, Daisy
    Geer, Eliza B.
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (02) : 313 - +
  • [6] Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome
    He, Xin
    Findling, James W.
    Auchus, Richard J.
    [J]. PITUITARY, 2022, 25 (03) : 393 - 403
  • [7] Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome
    Xin He
    James W. Findling
    Richard J. Auchus
    [J]. Pituitary, 2022, 25 : 393 - 403
  • [8] Invasive fungal infections in endogenous Cushing's syndrome
    Scheffel, Rafael Selbach
    Dora, Jose Miguel
    Weinert, Leticia Schwerz
    Aquino, Valerio
    Maia, Ana Luiza
    Canani, Luis Henrique
    Goldoni, Luciano Z.
    [J]. INFECTIOUS DISEASE REPORTS, 2010, 2 (01) : 9 - +
  • [9] Levoketoconazole: a novel treatment for endogenous Cushing's syndrome
    Fleseriu, Maria
    Auchus, Richard J.
    Pivonello, Rosario
    Salvatori, Roberto
    Zacharieva, Sabina
    Biller, Beverly M. K.
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2021, 16 (04) : 159 - 174
  • [10] The incidence of endogenous Cushing's syndrome in the modern era
    Wengander, Sofie
    Trimpou, Penelope
    Papakokkinou, Eleni
    Ragnarsson, Oskar
    [J]. CLINICAL ENDOCRINOLOGY, 2019, 91 (02) : 263 - 270